FERTILITY FOLLOWING DISCONTINUATION OF HORMONAL CONTRACEPTION


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To study fertility after completing the use of reversible hormonal contraceptive methods: combined oral contraception and levonorgestrel-releasing intrauterine system (IUS). Subject and methods. The authors made a retrospective analysis of 120 outpatient cards of patients who used hormonal contraception and sought medical advice after discontinuation of the method to plan pregnancy. The f indings were compared with published data from 17 prospective trials. Results and conclusion. The performed comparative analysis has led to the conclusion that hormonal contraception (combined oral contraception and levonorgestrel-releasing IUS) has no negative impact on fertility, the course of pregnancy, labor, delivery, and fetal status. The duration of using the above methods does not affect the time of fertility restoration.

Full Text

Restricted Access

About the authors

Marina Anatolievna Tarasova

D.O. Ott Research Institute of Obstetrics and Gynecology, West-Northern Branch, Russian Academy of Medical Sciences

Email: tarasova@ott.ru
M.D., prof., Deputy director for scientific work 199034, Russia, St. Petersburg, Mendeleevskaia Lain 3

Kira Anatolievna Shapovalova

I.P. Pavlov St. Petersburg State Medical University

Email: shаpovalova@ott.ru
PhD, assistant department of obstetrician and genecology 197022, Russia, St. Petersburg, Lev Tolstoy str. 6/8

References

  1. Sihvo S., Hemminki E., Kosunen E. Contraceptive health risks - women’s perceptions. J. Psychosom. Obstet. Gynaecol. 1998; 19: 117-25.
  2. Czeizel A.E., Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 1992; 327: 1832-5.
  3. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet. 1991; 338: 131-7.
  4. Salerno P., Bianchi F., Pierini A., Baldi F., Carbone P., Mantovani A., Taruscio D. Folic acid and congenital malformation: scientific evidence and public health strategies. Ann. Ig. 2008; 20(6): 519-30.
  5. Botto L.D., Olney R.S., Erickson J.D. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am. J. Med. Genet. C: Semin. Med. Genet. 2004; 125C(1): 12-21.
  6. Czeizel A.E. Periconceptional folic acid-containing multivitamin supplementation. Eur. J. Obstet. Gynecol. Reprod. Biol. 1998; 75: 151-61.
  7. Czeizel A.E. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am. J. Med. Genet. 1996; 62: 179- 83.
  8. Perlman S.E., Richmond D.M., Sabatini M.M., Krueger H., Rudy S.J. Contraception. Myths, facts and methods. J. Reprod. Med. 2001; 46: 169-77.
  9. Hitchcock C.L., Prior J.C. Evidence about extending the duration of oral contraceptive use to suppress menstruation. Womens Health Issues. 2004; 14(6): 201-11.
  10. Cronin M., Schellschmidt I., Dinger J. Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives. Obstet. Gynecol. 2009; 114: 616-22.
  11. Wiegratz I., Mittmann K., Dietrich H., Zimmermann T., Kuhl H. Fertility after discontinuation of treatment with an oral contraceptive containing 30 mcg of ethinyl estradiol and 2 mg of dienogest. Fertil. Steril. 2006; 85: 1812-9.
  12. Zimmermann T., Dietrich H., Wisser K.H., Munch C. Fertility after discontinuation of the dienogest-containing oral contraceptive Valette. First data of an ongoing study. Drugs Today. 1999; 35(Suppl.C): 89-95.
  13. Delbarge W., Batar I., Bafort M., Bonnivert J., Colmant C., Dhont M. et al. Return to fertility in nulliparous and parous women after removal of the GyneFix intrauterine contraceptive system. Eur. J. Contracept. Reprod. Health. Care. 2002; 7(1): 24-30.
  14. Tadesse E. Return of fertility after an IUD removal for planned pregnancy: a six-year prospective study. East Afr. Med. J. 1996; 73(3): 169-71.
  15. Andersson K., Batar I., Rybo G. Return to fertility after removal of a levonorgestrel -releasing intrauterine device and Nova-T. Contraception. 1992; 46: 575-84.
  16. Sivin I., Stern J., Diaz S., Pavéz M., Alvarez F., Brache V. et al. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel- releasing or copper TCu 380Ag intrauterine contraceptive devices. Am. J. Obstet. Gynecol. 1992; 166(4): 1208-13.
  17. Skjeldestad F.E., Bratt H. Return of fertility after use of IUDs (Nova-T, MLCu250 and MLCu375). Adv. Contracept. 1987; 3(2): 139-45.
  18. Belhadj H., Sivin I., Diaz S., Pavez M., Tejada A.S., Brache V. et al. Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device. Contraception. 1986; 34(3): 261-7.
  19. Anonymous. ICMR (Indian Council of Medical Research) Task Force on Hormonal Contraception. Return of fertility following discontinuation of an injectable contraceptive-norethisterone enanthate (NET EN) 200mg dose. Contraception. 1986; 34: 573-82.
  20. Affandi B., Santoso S., Djajadilaga, Hadisaputra W., Moeloek F.A., Prihartono J. et al. Pregnancy after removal of Norplant implants contraceptive. Contraception. 1987; 36(2): 203-9.
  21. Hassan J., Kulenthran A., Thum Y.S. The return of fertility after discontinuation of oral contraception in Malaysian women. Med. J. Malaysia. 1994; 49: 348-50.
  22. Ang Eng S., Arshat H. Pregnancy after contraceptive use. Malays. J. Reprod. Health. 1986; 4: 6-11.
  23. Linn S., Schoenbaum S.C., Monson R.R., Rosner B., Ryan K.J. Delay in conception for former ‘pill’ users. JAMA. 1982; 247(5): 629-32.
  24. Hassan M.A., Killick S.R. duced fecundity? Hum. Reprod. 2005; 20: 657-64.
  25. Gnoth C., Godehardt D., Godehardt E., Frank-Herrmann P., Freundl G. Time to pregnancy: results of the German prospective study and impact on the management of infertility. Hum. Reprod. 2003; 18: 1959-66.
  26. Gupta B.K., Gupta A.N., Lyall S. Return of fertility in various types of IUD users. Int. J. Fertil. 1989; 34: 123-5.
  27. Randic L., Vlasic S., Matrljan I., Waszak C.S. Return to fertility after IUD removal for planned pregnancy. Contraception. 1985; 32: 253-9.
  28. Buckshee K., Chatterjee P., Dhall G.I., Hazra M.N., Kodkany B.S., Lalitha K. et al. Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception. Contraception. 1995; 51(4): 237-42.
  29. Bahamondes L., Lavin P., Ojeda G., Petta C., Diaz J., Maradiegue E., Monteiro I. Return of fertility after discontinuation of the once-a-month injectable contraceptive Cyclofem. Contraception. 1997; 55(5): 307-10.
  30. Diaz S., Pavez M., Cardenas H., Croxatto H.B. Recovery of fertility and outcome of planned pregnancies after the removal of Norplant subdermal implants or Copper-T IUDs. Contraception. 1987; 35: 569-79.
  31. American Society for Reproductive Medicine. Smoking and infertility. Fertil. Steril. 2004; 81: 1181-6.
  32. Sweet R.L. Sexually transmitted diseases. Pelvic inflammatory disease and infertility in women. Infect. Dis. Clin. North Am. 1987; 1(1): 199-215.
  33. Stanford J.B., White G.L., Hatasaka H. Timing intercourse to achieve pregnancy: current evidence. Obstet. Gynecol. 2002; 100: 1333-41.
  34. Wilcox A.J., Weinberg C.R., Baird D.D. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N. Engl. J. Med. 1995; 333: 1517-21.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies